PROphylaxis for vulnerable paTiEnts at risk of COVID-19 infecTion (PROTECT-V): A basket trial of prophylactic interventions in multiple at-risk patient groups
- Funded by LifeArc
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
LifeArcResearch Location
United KingdomLead Research Institution
University of CambridgeResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Prophylactic use of treatmentsSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
UnspecifiedBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
A trial investigating the efficacy of Niclosamide as a preventative drug against COVID-19 infection in vulnerable patient groups including patients on dialysis, patients with vasculitis and transplant patients. This a basket trial design allowing for the addition of further interventions and patient groups at later time points. Where possible appointments and testing will be carried out remotely to avoid any undue risk to patients.